Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality.
作者信息
Bernigaud C, Guillemot D, Ahmed-Belkacem A, Grimaldi-Bensouda L, Lespine A, Berry F, Softic L, Chenost C, Do-Pham G, Giraudeau B, Fourati S, Chosidow O
机构信息
APHP, Hôpital Henri-Mondor, Université Paris-Est, Créteil, France.
Research Group Dynamic, Université Paris-Est Créteil, Créteil, France.
出版信息
Br J Dermatol. 2021 Jun;184(6):1207-1209. doi: 10.1111/bjd.19821. Epub 2021 Mar 1.
Abstract
摘要
相似文献
1
Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality.长期护理机构疥疮暴发时口服伊维菌素：在预防新冠病毒病及相关死亡方面的潜在价值
Br J Dermatol. 2021 Jun;184(6):1207-1209. doi: 10.1111/bjd.19821. Epub 2021 Mar 1.
2
Ivermectin in the management of a scabies outbreak in a long-term care facility.伊维菌素在长期护理机构疥疮暴发管理中的应用
Br J Dermatol. 2021 Oct;185(4):868. doi: 10.1111/bjd.20484. Epub 2021 Jul 14.
3
An Undiagnosed Index Case Leading to a Nosocomial Scabies Outbreak: How Mass Single-Dose Ivermectin Treatment Can Help Control a Nosocomial Epidemic.一例未确诊的索引病例引发医院疥疮暴发：大剂量单剂量伊维菌素治疗如何有助于控制医院感染流行。
Infect Control Hosp Epidemiol. 2018 May;39(5):631-632. doi: 10.1017/ice.2018.31. Epub 2018 Feb 19.
4
Use of ivermectin for the management of scabies in a nursing home.伊维菌素在养老院疥疮管理中的应用。
Eur J Dermatol. 1999 Sep;9(6):443-5.
5
Scabies: Diagnostic and Therapeutic Update.疥疮：诊断与治疗的最新进展。
J Cutan Med Surg. 2021 Jan-Feb;25(1):95-101. doi: 10.1177/1203475420960446. Epub 2020 Sep 30.
6
An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control.一家长期护理机构中的疥疮暴发：误诊的作用及控制相关成本
Infect Control Hosp Epidemiol. 2006 May;27(5):517-8. doi: 10.1086/504365. Epub 2006 Apr 20.
7
Control of large institutional scabies outbreaks.控制大型机构疥疮疫情。
J Dtsch Dermatol Ges. 2012 Sep;10(9):637-47. doi: 10.1111/j.1610-0387.2012.07892.x. Epub 2012 Mar 28.
8
[Nosocomial outbreak of scabies in a psychiatric hospital--epidemiological assessment and prophylactic treatment with oral ivermectin].[一家精神病医院疥疮的医院内暴发——流行病学评估及口服伊维菌素的预防性治疗]
Nihon Eiseigaku Zasshi. 2005 Nov;60(4):450-60. doi: 10.1265/jjh.60.450.
9
Effects of the COVID-19 pandemic on head lice and scabies infestation dynamics: a population-based study in France.新冠疫情对头虱和疥疮感染动态的影响：法国一项基于人群的研究
Clin Exp Dermatol. 2022 May;47(5):867-872. doi: 10.1111/ced.15054. Epub 2022 Jan 5.
10
[Scabies outbreak in a hospital and in 8 health-care institutions caused by an elderly patient with scabies crustosa].[一名患有结痂性疥疮的老年患者导致医院及8家医疗机构发生疥疮暴发]
Ned Tijdschr Geneeskd. 2006 Apr 22;150(16):918-23.
引用本文的文献
1
Single dose ivermectin for scabies pre-emptive therapy among healthcare workers in Careggi University Hospital, Florence, Italy.意大利佛罗伦萨卡雷吉大学医院医护人员疥疮预防治疗的单剂量伊维菌素研究
Infez Med. 2024 Dec 1;32(4):518-524. doi: 10.53854/liim-3204-10. eCollection 2024.
2
Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial.口服伊维菌素治疗轻至中度新型冠状病毒肺炎患者的疗效和安全性：一项多中心、双盲、随机对照临床试验。
BMC Infect Dis. 2024 Jul 22;24(1):719. doi: 10.1186/s12879-024-09563-y.
3
Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection.伊维菌素在治疗和预防 SARS-CoV-2 感染方面的潜在用途。
Curr Res Transl Med. 2021 Oct;69(4):103309. doi: 10.1016/j.retram.2021.103309. Epub 2021 Aug 11.
4
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.伊维菌素对 SARS-CoV-2 感染的临床和免疫结果的衰减作用。
EMBO Mol Med. 2021 Aug 9;13(8):e14122. doi: 10.15252/emmm.202114122. Epub 2021 Jul 12.
5
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.伊维菌素用于预防和治疗 COVID-19 感染：系统评价、荟萃分析和试验序贯分析，为临床指南提供信息。
Am J Ther. 2021 Jun 21;28(4):e434-e460. doi: 10.1097/MJT.0000000000001402.
6
Ivermectin as a potential treatment for COVID-19?伊维菌素能否作为治疗新冠肺炎的潜在药物？
PLoS Negl Trop Dis. 2021 Jun 1;15(6):e0009446. doi: 10.1371/journal.pntd.0009446. eCollection 2021 Jun.
本文引用的文献
1
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.使用伊维菌素与 COVID-19 住院患者的死亡率降低相关：COVID-19 中的伊维菌素研究。
Chest. 2021 Jan;159(1):85-92. doi: 10.1016/j.chest.2020.10.009. Epub 2020 Oct 13.
2
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
3
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses.伊维菌素与新冠病毒：《抗病毒研究》上的一篇报告、广泛关注、美国食品药品监督管理局的警告、致编辑的两封信以及作者的回应
Antiviral Res. 2020 Jun;178:104805. doi: 10.1016/j.antiviral.2020.104805. Epub 2020 Apr 21.
4
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.在一家专业护理机构中出现的 SARS-CoV-2 感染前驱期和传播。
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
5
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
6
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.华盛顿州金县长期护理机构中 COVID-19 的流行病学。
N Engl J Med. 2020 May 21;382(21):2005-2011. doi: 10.1056/NEJMoa2005412. Epub 2020 Mar 27.
7
Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects.健康成年受试者中递增高剂量伊维菌素的安全性、耐受性和药代动力学。
J Clin Pharmacol. 2002 Oct;42(10):1122-33. doi: 10.1177/009127002401382731.
Zotero 插件